PTHrP(1–36) as a skeletal anabolic agent for the treatment of osteoporosis
Data up to Jan 2025
Total Citations Per Year
Abstract
References (40)
Effect of Oral Alendronate on Bone Mineral Density and the Incidence of Fractures in Postmenopausal Osteoporosis
1995 • 2,293 citations
Lethal skeletal dysplasia from targeted disruption of the parathyroid hormone-related peptide gene.
1994 • 1,138 citations
Estrogen Replacement Therapy and Fractures in Older Women
1995 • 834 citations
Anabolic Actions of Parathyroid Hormone on Bone*
1993 • 721 citations
Skeletal disease in primary hyperparathyroidism
1989 • 616 citations
Defining the roles of parathyroid hormone-related protein in normal physiology
1996 • 576 citations
Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism
1994 • 383 citations
Expression of parathyroid hormone-related peptide and its receptor messenger ribonucleic acids during fetal development of rats.
1995 • 365 citations
Effects of continuous and intermittent administration and inhibition of resorption on the anabolic response of bone to parathyroid hormone
1992 • 364 citations
Nucleolar Localization of Parathyroid Hormone-Related Peptide Enhances Survival of Chondrocytes under Conditions That Promote Apoptotic Cell Death
1995 • 337 citations
The Histomorphometry of Bone in Primary Hyperparathyroidism: Preservation of Cancellous Bone Structure*
1990 • 329 citations
Increased bone mineral density after parathyroidectomy in primary hyperparathyroidism.
1995 • 254 citations
Parathyroid Hormone for the Prevention of Bone Loss Induced by Estrogen Deficiency
1994 • 247 citations
Treatment of Postmenopausal Osteoporosis with Slow-Release Sodium Fluoride: Final Report of a Randomized Controlled Trial
1995 • 246 citations
Parathyroid Hormone-Related Protein as a Prohormone: Posttranslational Processing and Receptor Interactions*
1994 • 214 citations
ANABOLIC EFFECT OF LOW DOSES OF A FRAGMENT OF HUMAN PARATHYROID HORMONE ON THE SKELETON IN POSTMENOPAUSAL OSTEOPOROSIS
1976 • 209 citations
Short-term effects of recombinant human insulin-like growth factor I on bone turnover in normal women.
1993 • 171 citations
Longitudinal measurements of bone density and biochemical indices in untreated primary hyperparathyroidism.
1995 • 165 citations
An evaluation of several biochemical markers for bone formation and resorption in a protocol utilizing cyclical parathyroid hormone and calcitonin therapy for osteoporosis.
1993 • 164 citations
The Parathyroids: Basic and Clinical Concepts
1994 • 162 citations
Mild Asymptomatic Primary Hyperparathyroidism Is Not a Risk Factor for Vertebral Fractures
1988 • 161 citations
Human parathyroid hormone (1–34) and (1–84) increase the mechanical strength and thickness of cortical bone in rats
1993 • 158 citations
Bone structure in postmenopausal hyperparathyroid, osteoporotic, and normal women
1995 • 145 citations
Maintenance of cancellous bone connectivity in primary hyperparathyroidism: Trabecular strut analysis
1992 • 144 citations
Humoral Hypercalcemia of Malignancy
1988 • 125 citations
Parathyroid hormone-related protein. Evidence for secretion of a novel mid-region fragment by three different cell types.
1992 • 122 citations
The Parathyroids: Basic and Clinical Concepts
1994 • 109 citations
Comparison of the Anabolic Effects of Synthetic Parathyroid Hormone-Related Protein (PTHrP) 1–34 and PTH 1–34 on Bone in Rats*
1989 • 105 citations
Bone mineral density in patients with chronic hypoparathyroidism.
1993 • 100 citations
A double-blind, placebo-controlled, dose-finding trial of intermittent nasal salmon calcitonin for prevention of postmenopausal lumbar spine bone loss
1995 • 87 citations
Parathyroid hormone (PTH)-related protein(1-36) is equipotent to PTH(1-34) in humans.
1996 • 86 citations
Effects of growth hormone and insulin-like growth factor I in men with idiopathic osteoporosis.
1996 • 83 citations
Attenuation of postmenopausal high turnover bone loss in patients with hypoparathyroidism.
1995 • 77 citations
A comparison of the in vivo biochemical responses to exogenous parathyroid hormone-(1-34) [PTH-(1-34)] and PTH-related peptide-(1-34) in man.
1992 • 74 citations
Effects of growth hormone and insulin-like growth factor I in men with idiopathic osteoporosis
1996 • 48 citations
The short term effects of tamoxifen on bone turnover in older women.
1995 • 48 citations
Parathyroid hormone-related protein as a prohormone: posttranslational processing and receptor interactions
1994 • 46 citations
Comparison of the pharmacokinetics of parenteral parathyroid hormone-(1-34) [PTH-(1-34)] and PTH-related peptide-(1-34) in healthy young humans.
1995 • 46 citations
Bone mineral density in patients with chronic hypoparathyroidism
1993 • 38 citations
Synthetic parathyroid hormone-like protein (1?74) is anabolic for bone in vivo
1992 • 35 citations